Published in Gene Therapy Weekly, August 9th, 2001
S.A. Rayner and colleagues at the University of London Imperial College of Science Technology and Medicine in London, U.K., hoped to extend corneal graft survival by expressing tumor necrosis factor receptor (TNFR) in corneal tissues. For this purpose, they constructed an adenovirus vector expressing a TNFR/immunoglobulin fusion protein (AdTNFR). Rabbit corneal tissue was transfected with AdTNFR ex vivo and expression was confirmed with enzyme-linked immunosorbent assay and bioassay. Ex vivo,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.